• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.

作者信息

Crickx Etienne, Moulis Guillaume, Ebbo Mikael, Terriou Louis, Briantais Antoine, Languille Laetitia, Limal Nicolas, Guillet Stéphanie, Michel Marc, Mahevas Matthieu, Godeau Bertrand

机构信息

Department of Internal Medicine, National Referral Center for Adult's Immune Cytopenias, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France.

Department of Internal Medicine, Toulouse University Hospital (CHU de Toulouse), Toulouse, France.

出版信息

Br J Haematol. 2021 Dec;195(5):703-705. doi: 10.1111/bjh.17813. Epub 2021 Aug 31.

DOI:10.1111/bjh.17813
PMID:34467525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8653340/
Abstract
摘要

相似文献

1
Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.免疫性血小板减少症患者接种抗SARS-CoV-2疫苗的安全性
Br J Haematol. 2021 Dec;195(5):703-705. doi: 10.1111/bjh.17813. Epub 2021 Aug 31.
2
Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature.新型冠状病毒肺炎疫苗接种后严重免疫性血小板减少症：4例报告及文献复习
Blood Cells Mol Dis. 2021 Dec;92:102615. doi: 10.1016/j.bcmd.2021.102615. Epub 2021 Oct 7.
3
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.多国静脉血栓栓塞症注册研究中，接种 SARS-CoV-2 疫苗后 30 天内的静脉血栓栓塞症。
Viruses. 2022 Jan 18;14(2):178. doi: 10.3390/v14020178.
4
Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination.免疫性血小板减少症（ITP）：COVID-19疫苗接种后的复发与新发
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296211073920. doi: 10.1177/10760296211073920.
5
Platelet trends after Covid-19 vaccination in patients with chronic or persistent immune thrombocytopenia.慢性或持续性免疫性血小板减少症患者接种新冠疫苗后的血小板变化趋势
Am J Hematol. 2021 Dec 1;96(12):E472-E474. doi: 10.1002/ajh.26366. Epub 2021 Oct 19.
6
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.尽管接种了mRNA疫苗加强针，但仍出现了新冠病毒奥密克戎变异株突破性感染。
Lancet. 2022 Feb 12;399(10325):625-626. doi: 10.1016/S0140-6736(22)00090-3. Epub 2022 Jan 18.
7
Reactogenicity among health care workers following a BNT162b2 or mRNA-1273 second dose after priming with a ChAdOx1 nCOV-19 vaccine.在使用 ChAdOx1 nCOV-19 疫苗进行初级免疫后，BNT162b2 或 mRNA-1273 第二针后医护人员的不良反应率。
Clin Microbiol Infect. 2022 Jun;28(6):885.e1-885.e5. doi: 10.1016/j.cmi.2022.02.010. Epub 2022 Feb 16.
8
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma.多发性骨髓瘤患者两剂 SARS-CoV-2 信使 RNA 疫苗接种的安全性和抗体反应。
BMC Cancer. 2021 Dec 27;21(1):1354. doi: 10.1186/s12885-021-09097-5.
9
Immune Responses to the ChAdOx1 nCoV-19 and BNT162b2 Vaccines and to Natural Coronavirus Disease 2019 Infections Over a 3-Month Period.在三个月期间内对 ChAdOx1 nCoV-19 和 BNT162b2 疫苗以及对自然发生的 2019 年冠状病毒病感染的免疫应答。
J Infect Dis. 2022 Mar 2;225(5):777-784. doi: 10.1093/infdis/jiab579.
10
Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.一名22岁接种新冠疫苗后出现的免疫性血小板减少症。
Am J Hematol. 2021 May 1;96(5):E133-E134. doi: 10.1002/ajh.26106. Epub 2021 Feb 11.

引用本文的文献

1
Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis.接种 SARS-CoV-2 疫苗后免疫介导性疾病患者出现 flares 或复发的风险：一项系统评价和荟萃分析。
Eur J Med Res. 2024 Jan 17;29(1):55. doi: 10.1186/s40001-024-01639-4.
2
Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective.双膦酸盐在老年免疫性血小板减少症糖皮质激素诱导骨质疏松症患者中的应用：临床视角。
Ann Hematol. 2023 Jul;102(7):1645-1656. doi: 10.1007/s00277-023-05266-7. Epub 2023 May 12.
3
Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management.免疫性血小板减少症峰会会议记录：发病机制、诊断及管理的新概念
Res Pract Thromb Haemost. 2023 Feb 27;7(2):100097. doi: 10.1016/j.rpth.2023.100097. eCollection 2023 Feb.
4
COVID-19 vaccination and immune thrombocytopenia: Cause for vigilance, but not panic.2019冠状病毒病疫苗接种与免疫性血小板减少症：需保持警惕，但勿恐慌。
Res Pract Thromb Haemost. 2023 Jan;7(1):100039. doi: 10.1016/j.rpth.2023.100039. Epub 2023 Feb 15.
5
Older Adults and Immune Thrombocytopenia: Considerations for the Clinician.老年人与免疫性血小板减少症：临床医生的相关考虑。
Clin Interv Aging. 2023 Jan 26;18:115-130. doi: 10.2147/CIA.S369574. eCollection 2023.
6
Early recognition and treatment of pre-VITT syndrome after adenoviral vector-based SARS-CoV-2 vaccination may prevent from thrombotic complications: review of published cases and clinical pathway.基于腺病毒载体的SARS-CoV-2疫苗接种后早期识别和治疗疫苗诱导的免疫性血栓性血小板减少综合征（pre-VITT）可能预防血栓形成并发症：已发表病例综述及临床路径
Eur Heart J Open. 2022 May 16;2(3):oeac036. doi: 10.1093/ehjopen/oeac036. eCollection 2022 May.
7
SARS-CoV-2 vaccination in pediatric patients with immune thrombocytopenia.免疫性血小板减少症儿科患者的新型冠状病毒2型疫苗接种
Pediatr Blood Cancer. 2022 Jul;69(7):e29760. doi: 10.1002/pbc.29760. Epub 2022 May 13.
8
De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring.新型冠状病毒肺炎疫苗接种后新发和复发性免疫性血小板减少症：法国安全性监测结果
Blood. 2022 Apr 21;139(16):2561-2565. doi: 10.1182/blood.2022015470.
9
Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.新型冠状病毒病和 SARS-CoV-2 疫苗接种中的凝血障碍和纤维蛋白溶解病理生理学。
Int J Mol Sci. 2022 Mar 19;23(6):3338. doi: 10.3390/ijms23063338.
10
Real-world, single-center experience of SARS-CoV-2 vaccination in immune thrombocytopenia.真实世界、单中心免疫性血小板减少症患者接种 SARS-CoV-2 疫苗的经验。
J Thromb Haemost. 2022 Jun;20(6):1476-1484. doi: 10.1111/jth.15704. Epub 2022 Apr 5.

本文引用的文献

1
Exacerbation of immune thrombocytopenia following COVID-19 vaccination.接种 COVID-19 疫苗后免疫性血小板减少症恶化。
Br J Haematol. 2021 Nov;195(3):365-370. doi: 10.1111/bjh.17645. Epub 2021 Jun 24.
2
Immune thrombocytopenia during the COVID-19 pandemic.新冠疫情期间的免疫性血小板减少症
Br J Haematol. 2021 Jun;193(6):1093-1095. doi: 10.1111/bjh.17457. Epub 2021 Apr 14.
3
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.辉瑞和莫德纳新冠疫苗接种后出现的血小板减少症。
Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9.
4
Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.新型冠状病毒肺炎相关免疫性血小板减少症的临床特征、管理及结局：一项法国多中心研究系列
Br J Haematol. 2020 Aug;190(4):e224-e229. doi: 10.1111/bjh.17024. Epub 2020 Aug 4.
5
Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19.血小板减少症与因新冠肺炎住院患者的不良预后独立相关。
Br J Haematol. 2020 Sep;190(5):e276-e279. doi: 10.1111/bjh.16950. Epub 2020 Aug 31.
6
COVID-19 presenting with immune thrombocytopenia: A case report and review of the literature.新型冠状病毒肺炎合并免疫性血小板减少症：一例病例报告及文献复习
J Med Virol. 2021 Jan;93(1):43-45. doi: 10.1002/jmv.26138. Epub 2020 Jun 29.
7
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
8
American Society of Hematology 2019 guidelines for immune thrombocytopenia.美国血液学会 2019 年免疫性血小板减少症治疗指南。
Blood Adv. 2019 Dec 10;3(23):3829-3866. doi: 10.1182/bloodadvances.2019000966.